Results 71 to 80 of about 592,747 (102)

Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) against natural flea and tick infestations on dogs presented as veterinary patients in Europe

Parasites & Vectors, 2021
Background A pivotal randomised, blinded, positive-controlled, multicentre, European field study was conducted to evaluate the effectiveness and safety of a novel combination tablet of lotilaner and milbemycin oxime (Credelio® Plus) administered orally ...
Sophie Forster, Scott Wiseman, Daniel E. Snyder   +2 more
doaj   +1 more source

Application of eprinomectin‐containing parasiticides at label doses causes neurological toxicosis in cats homozygous for ABCB11930_1931del TC

Journal of Veterinary Pharmacology and Therapeutics, Volume 47, Issue 3, Page 226-230, May 2024.
Abstract The feline MDR1 mutation (ABCB11930_1931delTC) has been associated with neurological toxicosis after topical application of eprinomectin products labeled for feline use. Information was collected from veterinarians who submitted samples for ABCB11930_1931delTC genotyping.
Katrina L. Mealey, Neal S. Burke, Nicolas F. Villarino, Michael H. Court, Jennifer P. Heusser   +4 more
wiley   +1 more source

Preference of Dogs between Two Oral Formulations of Endectoparasiticides: NEXGARD SPECTRA ® (Afoxolaner and Milbemycin Oxime) and Simparica Trio TM (Sarolaner, Moxidectin and Pyrantel) Preference of Dogs between Two Oral Formulations of Endectoparasiticides: NEXGARD SPECTRA (Afoxolaner and Milbemycin Oxime) and Simparica Trio TM

, 2020
International audiencePet owner compliance is essential for the success of veterinary healthcare strategies. As some parasites are zoonotic, consistent parasite control is an integral part of the One-Health strategy.
Chalvet-Monfray, Karine, Gross, Sheila, Everett, William Russel, Perier, Nadège, Wongnak, Phrutsamon, Beugnet, Frédéric, Carithers, Douglas   +6 more
core   +1 more source

ç©æ¥­ç®¡çå¬å¸æåå®å¹æ¨¡å¼ä¹å»ºç«

, 2014
æåä¹ç©æ¥­ç®¡ç(Property Management, PM)å¬å¸ä¹ç¢åï¼ç©ç®¡æåçå質èå¹æ ¼çºå½±é¿ç©ç®¡å¬å¸ç¶ç績æä¹ééµã檢è¦ç¾ä»ç©æ¥­ç®¡çç¢æ¥­ä¹æ¦æ³ï¼ç±æ¼åå°åå§æ³ä»¤ä¸å¥å¨åé²å¥é檻è¼ä½ä¹å½±é¿ï¼ä»¥è³æ¼ç©æ¥­ç®¡ç業èèæ¼åå競ç­çç°å¢ï¼é²èé æ業èé競ç­åå¹å½±é¿å¶å質èå©æ½¤ãçºæ­¤ï¼åå ...
è¡æä¿®
core   +1 more source

Clinical efficacy of a parasiticide formulation containing eprinomectin, esafoxolaner and praziquantel (NexGard® Combo) in the treatment of natural feline aelurostrongylosis and troglostrongylosis

The metastrongyloids Aelurostrongylus abstrusus and Troglostrongylus brevior are primary causes of feline clinical respiratory disease. The present field trial evaluated the clinical efficacy of a spot-on formulation containing eprinomectin, esafoxolaner
Beugnet, Frederic, Vignoli, Massimo, Tielemans, Eric, Traversa, Donato, Crisi, Paolo Emidio, Iorio, Raffaella, Veronesi, Fabrizia, Colombo, Mariasole, Rigamonti, Giulia, Di Cesare, Angela, Gamblin, Camille, Morelli, Simone   +11 more
core   +1 more source

Efficacy of oral afoxolaner plus milbemycin oxime chewable (NexGard Spectra®, Merial) to prevent heartworm disease in dogs after inoculation with third stage larvae of Dirofilaria immitis

, 2015
The novel combination of afoxolaner plus milbemycin oxime, NexGard Spectra®, was evaluated against the migrating Dirofilaria immitis larvae in beagle dogs in two negative control, blinded laboratory studies. In each study, dogs were randomly allocated
Tielemans, Eric, Lebon, Wilfried, Larsen, Diane, Dumont, Pascal, GENCHI, Marco, Jeannin, Philippe   +5 more
core  

Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations [PDF]

Advances in proteomic assay methodologies and genomics have significantly improved our understanding of the blood proteome. Schizophrenia and psychosis risk are linked to polygenic scores for schizophrenia and other mental disorders, as well as to ...
Perkins, Diana O., Klauser, Paul, Winter-van Rossum, Inge, Calkins, Monica E., Jeffries, Clark D., Walker, Elaine, Wray, Naomi R., Clark, Scott R., Upthegrove, Rachel, Cerrato, Felecia, Khadimallah, Ines, Mongan, David, Barbee, Jenna, Ellman, Lauren M., Do, Kim Q., Li, Qingqin S., Billah, Tashrif, Corcoran, Cheryl, Wannan, Cassandra M. J., Anticevic, Alan, Roth, Sharin, Paul Amminger, G., Phassouliotis, Christina, Cotter, David, Kane, J.M., Kahn, Rene S., Nelson, Barnaby, Lauren M. Ellman, Inge Winter-van Rossum, Rene S. Kahn, Bleggi, Rachel S., Li, Q.S., Accelerating Medicines Partnership® Schizophrenia, Woods, Scott W., Catherine Toben, Paul Amminger, G, Khadimallah, I., Paul Klauser, Kahn, R.S., Shah, Jai L, Cheryl Corcoran, Clark, SR, David Cotter, Upthegrove, R, Wray, Naomi R, Pasternak, Ofer, Shah, J.L., Billah, T., Kane, John M., Martin, AR, Martin, Alicia R, Bearden, C.E., Barbee, J, Carrie E. Bearden, Khadimallah, I, Walker, E, Alicia R. Martin, Calkins, Monica E, G. Paul Amminger, McGorry, Patrick D, Wolf, DH, Li, QS, Do, KQ, Clark, S.R., Ellman, Lauren M, Bearden, Carrie E., Nelson, B., Jeffries, CD, Shah, Jai L., Bearden, Carrie E, Christina Phassouliotis, Scott W. Woods, Bouix, Sylvain, Anticevic, A, Winter-van Rossum, I., Alan Anticevic, Bouix, S., McGorry, Patrick D., Li, Qingqin S, Klauser, P, Scott R. Clark, Cotter, D, Naomi R. Wray, Qingqin S. Li, Rachel S. Bleggi, Wolf, D.H., Kim Q. Do, Corcoran, C., Kane, JM, Klauser, P., Nelson, B, Do, Kim Q, Winter-van Rossum, I, Kahn, Rene S, Ellman, LM, Upthegrove, R., Roth, S., Bleggi, R.S., Jenna Barbee, Ellman, L.M., Toben, C., Wray, NR, John M. Kane, Kahn, RS, Bleggi, Rachel S, David Mongan, Bearden, CE, Walker, E., Corcoran, C, Barbee, J., Ofer Pasternak, Mongan, D., Felecia Cerrato, Perkins, DO, Barnaby Nelson, Toben, C, Monica E. Calkins, Angela R. Nunez, Roth, S, Nunez, A.R., Wannan, CMJ, Shenton, Martha E., Suen, Yi Nam, Mongan, D, Wannan, Cassandra M J, Sylvain Bouix, Elaine Walker, Martha E. Shenton, Shenton, Martha E, Cassandra M. J. Wannan, Pasternak, O, Diana O. Perkins, Wolf, Daniel H, Clark D. Jeffries, Winter-van, Rossum Inge, Bouix, S, Paul, Amminger G, Ines Khadimallah, Martin, A.R., McGorry, PD, Sharin Roth, Jeffries, Clark D, Do, K.Q., Nunez, Angela R, Jai L. Shah, Cerrato, F., Bleggi, RS, Phassouliotis, C., McGorry, P.D., Calkins, M.E., Shenton, M.E., Shah, JL, Daniel H. Wolf, Clark, Scott R, Nunez, Angela R., Nunez, AR, Anticevic, A., Cerrato, F, Rachel Upthegrove, Woods, SW, Jeffries, C.D., Shenton, ME, Wolf, Daniel H., Tashrif Billah, Billah, T, Martin, Alicia R., Cotter, D., Woods, Scott W, Toben, Catherine, Kane, John M, Calkins, ME, Wray, N.R., Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ), Woods, S.W., Perkins, D.O., Phassouliotis, C, Patrick D. McGorry, Pasternak, O., Perkins, Diana O, Wannan, Cassandra M.J., Mongan, David; id_orcid   +180 more
core   +2 more sources

Action of synthetic acaricides: fluralaner (Bravecto®), afoxolaner (Nexgard®), sarolaner (Simparic®) and natural ozonized oil (Ozo3®) on the salivary glands of ticks Rhipicephalus linnaei (Acari: Ixodidae) and on the liver tissue of rabbits simulating hosts

Os carrapatos têm representado um problema zoonótico relevante nos últimos anos, no Brasil e no mundo. Além de espoliadores de seus hospedeiros eles são vetores de muitos patógenos para animais domésticos e mesmo para o homem. A espécie R.
Vinha, Eduarda Cristina da [UNESP]
core  

Ϻ┘äϬϡ┘ä┘è┘ä Ï╣┘å ÏÀÏ▒┘è┘éÏ® ϬÏ╣┘ä┘è┘à Ϻ┘ä┘äÏ║Ï® Ϻ┘äÏ╣Ï▒Ï¿┘èÏ® ┘ä┘äÏúÏÀ┘üϺ┘ä

, 2017
Ϻ┘äÏ╣Ϻ┘ä┘à Ϻ┘äϬÏ▒Ï¿┘èÏ® ┘éÏ» Ï╣Ï▒┘ü┘åϺ Ïú┘å Ϻ┘äÏÀÏ▒┘è┘éÏ® ┘äϬÏ╣┘ä┘è┘à Ϻ┘ä┘äÏ║Ï® Ϻ┘äÏ╣Ï▒Ï¿┘èÏ® ┘àϬ┘å┘êÏ╣Ï®Ïî ┘à┘å┘çϺ ÏÀÏ▒┘è┘éÏ® Ϻ┘äϻϿϺÏ┤Ï▒Ï®Ïî ÏÀÏ▒┘è┘éÏ® Ϻ┘ä┘é┘êϺÏ╣ϻϺ┘ä ϬÏ▒ϼ┘àϮϮ ÏÀÏ▒┘è┘éÏ® Ϻ┘äÏ│Ï╣Ï╣┘èÏ® Ϻ┘äÏ┤┘ü┘ê┘èÏ®Ïî ÏÀÏ▒┘è┘éÏ ...
Ï╣ϺϪÏ┤Ï®, Ï»┘è┘ü┘è
core   +1 more source

Saving a species, one mite at a time: efficacy of afoxolaner (NexGard®) against Macronyssidae mites in the critically endangered Aeolian wall lizard (<i>Podarcis raffonei</i>). [PDF]

Int J Parasitol Parasites Wildl
Mendoza-Roldan JA, Ricci A, Gambioli B, Sioumpoura K, Di Palma A, Montinaro G, Macale D, Vignoli L, Beugnet F, Otranto D.   +9 more
europepmc   +1 more source